Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 19, 2025 inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and Financial Year ended March 31, 2025 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2025.